Casein Kinase

Casein Kinase

The ubiquitous Ser/Thr kinases known as casein kinases (CKs) control a variety of cellular processes in eukaryotes, including the phosphorylation of proteins that are targets for degradation by the ubiquitin-proteasome system (UPS). Casein kinase-1 (CK-1) and casein kinase-2 (CK-2) have both been extensively characterized.
Mammals have at least seven different isoforms of CK1 kinases (,, 1-3,, and ), and these enzymes phosphorylate different substrates to participate in a variety of physiological processes including DNA repair, cell cycle progression, cytokinesis, differentiation, and apoptosis.A highly pleiotropic serine-threonine kinase called casein kinase 2 (CK2) phosphorylated more than 300 proteins, many of which are involved in the regulation of cellular processes like signal transduction, transcriptional control, apoptosis, and the cell cycle.

Casein Kinase related products

Structure Cat No. Product Name CAS No. Product Description
V55055 CK1-IN-2 1383376-92-8 CK1-IN-2 (compound Nr.4) is a potent CK1 inhibitor (antagonist) with IC50s of 123, 19.8, 26.8, and 74.3 nM for CK1a, CK1d, CK1e, and p38a, respectively.
V55058 CK1-IN-3 349438-74-0 CK1-IN-3 (compound 51) is an AC1 inhibitor (antagonist) with IC50 of 2.22 µM for CK-1δ.
V52245 CK2 inhibitor 2 2641079-92-5 CK2 inhibitor 2 is a specific and orally bioactive CK2 inhibitor (antagonist) with IC50 of 0.66 nM.
V55063 CK2-IN-4 313985-59-0 CK2-IN-4 (Compound 5) is a protein kinase (CK2) inhibitor (IC50=8.6 µM).
V55057 CK2-IN-6 1309835-18-4 CK2-IN-6 is a potent inhibitor of the protein kinase CK2 and may be utilized in the study of cancer and other kinase-related conditions such as inflammation, pain and certain immune diseases.
V55059 CK2-IN-7 2920559-18-6 CK2-IN-7 (compound 2) is an inhibitor (blocker/antagonist) of casein kinase CK2.
V55060 CK2-IN-9 1461658-58-1 CK2-IN-9 is a potent and specific inhibitor of CK2 kinase with IC50 of 3 nM.
V69788 CK2α-IN-1 443747-52-2 CK2α-IN-1 (compound 2) is a selective CK2α inhibitor (IC50=7.0 µM; Ki=1.6 µM), which displays a non-ATP competitive mode of action.
V69798 Ellagic acid (hydrate) 314041-08-2 Ellagic acid hydrate is a natural antioxidant and a potent, ATP-competitive CK2 inhibitor (antagonist) with IC50 and Kis of 40 nM and 20 nM respectively.
V52646 Emodin-d4 (Frangula emodin-d4) 132796-52-2 Emodin-d4 is the deuterium labelled form of Emodin.
V52083 FPFT-2216 2367619-87-0 FPFT-2216 is a "molecular glue" compound that degrades phosphodiesterase 6D (PDE6D), zinc finger transcription factors Ikaros (IKZF1), Aiolos (IKZF3), and casein kinase 1α (CK1α).
V55053 IQA (CGP-029482) 391670-48-7 IQA (CGP-029482) is a potent and specific inhibitor of protein kinase CK2.
V51919 JNJ-6204 2765264-50-2 JNJ-6204 is a dual (bifunctional) inhibitor of CSNK1D and CSNK1E (CSNK1D IC50=2.3 nM; CSNK1E IC50=137 nM) and has good brain penetration.
V24087 LH846 639052-78-1 LH846 is a selective CKIδ inhibitor (antagonist) with IC50 of 290 nM; its inhibitory activity against CKIα and CKIε is relatively weak, with IC50s of 2.5 μM and 1.3 μM respectively.
V5237 Longdaysin 1353867-91-0 Longdaysin is a novel and potent inhibitor of Casein Kinase (CK1α, CK1δ, CDK7) and ERK2 with IC50s of  5.6 µM, 8.8 µM, 29 µM, and 52 µM, respectively.
V76739 MU1742 MU1742 is a probe for the detection of CK1δ and CK1ε kinases.
V55065 ON 108600 1585246-23-6 ON 108600 is an inhibitor (blocker/antagonist) of CK2 (Casein Kinase2)/TNIK/DYRK1.
V41060 Orobol 480-23-9 Orobol is a major soy isoflavone with multiple bioactivities such as anti-skin aging and anti-obesity effects.
V9819 Quinalizarin 81-61-8 Quinalizarin is a potent, ATP-competitive, and highly selective (IC50 >1μM against CK1 and 72 other kinases) casein Kinase II (CK2) inhibitor (IC50= 110nM),superior to the first-in-class CK2 inhibitor, CX-4945.
V36627 SGC-CK2-1 2470424-39-4 SGC-CK2-1 is a highly efficient, ATP-competitive CK2 chemical probe that is selective for two human CK2 isoforms, CK2α and CK2α', with IC50s of 36 and 16 nM, respectively.
Contact Us Back to top